“Real-World Effectiveness and Safety of Glecaprevir Pibrentasvir Therapy in Patients With Chronic Hepatitis C Virus Infection in Switzerland”. Swiss Medical Weekly, vol. 151, no. 0304, Jan. 2021, p. w20399, https://doi.org/10.4414/smw.2021.20399.